Anecdotal evidence suggests that the severity of coronavirus disease of 2019 (COVID-19),
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is likely to be …

Immunity against respiratory pathogens is often short-term, and, consequently, there is an
unmet need for the effective prevention of such infections. One such infectious disease is …

There is increasing evidence of both central and peripheral nervous system (PNS)
involvement in COVID-19. We conducted this systematic literature review to investigate the …

Objective To describe the frequency of neuropsychiatric complications among hospitalized
patients with coronavirus disease 2019 (COVID-19) and their association with pre-existing …

Theoretical considerations related to neurological post-COVID complications have become
a serious issue in the COVID pandemic. We propose 3 theoretical hypotheses related to …

Abstract Many coronavirus disease 2019 (COVID‐19) positive individuals exhibit abnormal
electroencephalographic (EEG) activity reflecting “brain fog” and mild cognitive impairments …

The balance between neurodegeneration, neuroinflammation, neuroprotection, and COVID-
19-directed therapy may underly the heterogeneity of SARS-CoV-2′ s neurological …

Purpose To compare the female sexual function before and during the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic using the Female Sexual …

Background and Objectives: Neurological manifestations have been reported in a significant
proportion of coronavirus disease 2019 (COVID-19) patients. We aimed to evaluate the …

Objective: To identify factors associated with posttraumatic stress symptoms (PTSS) 3 and 6
months after the discharge of patients hospitalized for COVID-19. Methods: Patients …